相似文献
1
The role of PI3Kγ in the immune system: new insights and translational implications.
Nat Rev Immunol. 2022 Nov;22(11):687-700. doi: 10.1038/s41577-022-00701-8. Epub 2022 Mar 23.
2
Targeting phosphatidylinositol 3-kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors.
Med Res Rev. 2021 May;41(3):1599-1621. doi: 10.1002/med.21770. Epub 2020 Dec 10.
3
Phosphoinositide 3 Kinase γ Plays a Critical Role in Acute Kidney Injury.
Cells. 2022 Feb 23;11(5):772. doi: 10.3390/cells11050772.
4
Designing Small Molecule PI3Kγ Inhibitors: A Review of Structure-Based Methods and Computational Approaches.
J Med Chem. 2024 Jul 11;67(13):10530-10547. doi: 10.1021/acs.jmedchem.4c00347. Epub 2024 Jun 19.
5
A class of highly selective inhibitors bind to an active state of PI3Kγ.
Nat Chem Biol. 2019 Apr;15(4):348-357. doi: 10.1038/s41589-018-0215-0. Epub 2019 Feb 4.
6
Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases.
J Med Chem. 2019 May 23;62(10):4783-4814. doi: 10.1021/acs.jmedchem.8b01298. Epub 2018 Dec 24.
7
Recent discovery of phosphoinositide 3-kinase γ inhibitors for the treatment of immune diseases and cancers.
Future Med Chem. 2019 Aug;11(16):2151-2169. doi: 10.4155/fmc-2019-0010.
8
PI3Kγ is a molecular switch that controls immune suppression.
Nature. 2016 Nov 17;539(7629):437-442. doi: 10.1038/nature19834. Epub 2016 Sep 19.
9
PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response.
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16). doi: 10.1073/pnas.2009290118.
10
PI3K Regulatory Protein p84 Determines Mast Cell Sensitivity to Ras Inhibition-Moving Towards Cell Specific PI3K Targeting?
Front Immunol. 2020 Oct 28;11:585070. doi: 10.3389/fimmu.2020.585070. eCollection 2020.
引用本文的文献
1
PI3Kγ signaling controls trafficking of CD8 T cells between lymphoid and non-lymphoid organs and drives hypertension in a murine model.
Nat Commun. 2025 Jul 1;16(1):5818. doi: 10.1038/s41467-025-61009-4.
2
The genomic legacy of selectively breeding rhesus macaques for HIV/AIDS-related research.
bioRxiv. 2025 May 28:2025.05.26.654976. doi: 10.1101/2025.05.26.654976.
3
Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches.
Cancers (Basel). 2025 May 1;17(9):1547. doi: 10.3390/cancers17091547.
4
Enhancing PI3Kγ inhibitor discovery: a machine learning-based virtual screening approach integrating pharmacophores, docking, and molecular descriptors.
Mol Divers. 2025 May 13. doi: 10.1007/s11030-025-11216-4.
5
Targeting PI3K Signaling to Overcome Tumor Immunosuppression: Synergistic Strategies to Enhance Cancer Vaccine Efficacy.
Vaccines (Basel). 2025 Mar 10;13(3):292. doi: 10.3390/vaccines13030292.
6
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects.
J Immunother Cancer. 2025 Apr 10;13(4):e011377. doi: 10.1136/jitc-2024-011377.
7
Vps34-orchestrated lipid signaling processes regulate the transitional heterogeneity and functional adaptation of effector regulatory T cells.
PLoS Biol. 2025 Apr 11;23(4):e3003074. doi: 10.1371/journal.pbio.3003074. eCollection 2025 Apr.
8
PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis.
Drugs. 2025 Jun;85(6):741-753. doi: 10.1007/s40265-025-02179-9. Epub 2025 Apr 11.
9
PI3K pathway activation in severe asthma is linked to steroid insensitivity and adverse outcomes.
J Allergy Clin Immunol Glob. 2025 Feb 12;4(2):100439. doi: 10.1016/j.jacig.2025.100439. eCollection 2025 May.
10
Epigenetic regulatory protein chromobox family regulates multiple signalling pathways and mechanisms in cancer.
Clin Epigenetics. 2025 Mar 13;17(1):48. doi: 10.1186/s13148-025-01852-w.
本文引用的文献
1
Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma.
J Med Chem. 2021 Jun 24;64(12):8053-8075. doi: 10.1021/acs.jmedchem.1c00434. Epub 2021 Jun 3.
2
Disease-related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors.
Elife. 2021 Mar 4;10:e64691. doi: 10.7554/eLife.64691.
3
Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation.
Haematologica. 2020 Oct 1;105(10):e488. doi: 10.3324/haematol.2019.231399.
4
The Growing Spectrum of Human Diseases Caused by Inherited CDC42 Mutations.
J Clin Immunol. 2020 May;40(4):551-553. doi: 10.1007/s10875-020-00785-8.
5
T cell subsets and functions in atherosclerosis.
Nat Rev Cardiol. 2020 Jul;17(7):387-401. doi: 10.1038/s41569-020-0352-5. Epub 2020 Mar 16.
6
Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study.
Clin Cancer Res. 2020 May 1;26(9):2096-2103. doi: 10.1158/1078-0432.CCR-19-3061. Epub 2020 Jan 21.
7
Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease.
Adv Biol Regul. 2020 Jan;75:100657. doi: 10.1016/j.jbior.2019.100657. Epub 2019 Sep 28.
8
Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology.
Nat Commun. 2019 Sep 25;10(1):4364. doi: 10.1038/s41467-019-12311-5.
9
Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of -encoded phosphoinositide 3-kinase δ.
Haematologica. 2019 Oct;104(10):e483-e486. doi: 10.3324/haematol.2018.208397. Epub 2019 May 9.
10
Insulin-Driven PI3K-AKT Signaling in the Hepatocyte Is Mediated by Redundant PI3Kα and PI3Kβ Activities and Is Promoted by RAS.
Cell Metab. 2019 Jun 4;29(6):1400-1409.e5. doi: 10.1016/j.cmet.2019.03.010. Epub 2019 Apr 11.
Zotero 插件